Bruno Crestani

Active 1994–2025

194
Papers
25,491
Citations
85
h-index
185
i10-index

Citations

Citations per year for Bruno Crestani1994: 1 citations1995: 2 citations1996: 15 citations1997: 9 citations1998: 15 citations1999: 21 citations2000: 22 citations2001: 23 citations2002: 24 citations2003: 21 citations2004: 25 citations2005: 18 citations2006: 28 citations2007: 29 citations2008: 46 citations2009: 43 citations2010: 64 citations2011: 69 citations2012: 96 citations2013: 113 citations2014: 144 citations2015: 138 citations2016: 205 citations2017: 194 citations2018: 235 citations2019: 860 citations2020: 982 citations2021: 1,069 citations2022: 985 citations2023: 845 citations2024: 1,424 citations2025: 575 citations2026: 14 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,246 citing papers, 20.5% of this breakdownChina: 1,053 citing papers, 9.6% of this breakdownFrance: 796 citing papers, 7.3% of this breakdownUnited Kingdom: 793 citing papers, 7.2% of this breakdownItaly: 697 citing papers, 6.4% of this breakdownGermany: 623 citing papers, 5.7% of this breakdownJapan: 554 citing papers, 5% of this breakdownCanada: 451 citing papers, 4.1% of this breakdownSpain: 338 citing papers, 3.1% of this breakdownNetherlands: 316 citing papers, 2.9% of this breakdownAustralia: 285 citing papers, 2.6% of this breakdownSwitzerland: 244 citing papers, 2.2% of this breakdown
0%20.5%Other 23.4%

Fields

  • Medicine79%
  • Biochemistry, Genetics and Molecular Biology11%
  • Immunology and Microbiology6.4%
  • Neuroscience0.7%
  • Environmental Science0.7%
  • Engineering0.5%
  • Other1.7%

Topics

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis17.3%
  • Systemic Sclerosis and Related Diseases4.5%
  • Sarcoidosis and Beryllium Toxicity Research3.4%
  • Chronic Obstructive Pulmonary Disease (COPD) Research3.2%
  • Inflammatory Myopathies and Dermatomyositis2.9%
  • Neonatal Respiratory Health Research2.5%
  • Other66.2%

Coauthors

All papers

Open in search
  1. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Ho, Julie Morisset, Amy L. Olson, Anna Podolanczuk, Venerino Poletti, Moisés Selman, Thomas Ewing, Stephen Jones, Shandra L. Knight, Marya Ghazipura, Kevin C. Wilson - American Journal of Respiratory and Critical Care Medicine 2022 cited by 2,618

  2. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey J. Swigris, Dominique Valeyre - American Journal of Respiratory and Critical Care Medicine 2013 cited by 4,273

  3. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Blaas, Benjamin Bondue, Francesco Bonella, E. James Britt, Ketan Buch, John R. Burk, Hourong Cai, André M. Cantin, D.M. Castillo Villegas, Agustina Díaz Cazaux, Stefania Cerri, Said Chaaban, Nazia Chaudhuri, Vincent Cottin, Bruno Crestani, Gerard J. Criner, Caroline Dahlqvist, Sonye K. Danoff, J. Dematte D'Amico, Daniel F. Dilling, Paulo Eduardo Elias, Neil Ettinger, Jeremy Falk, Evans R. Fernández Pérez, A. Gamez-Dubuis, G. Giessel, Alex H. Gifford, Marilyn K. Glassberg, Craig S. Glazer, Jeffrey A. Golden, Luis Gómez Carrera, Julien Guiot, Robert W. Hallowell, Hiroki Hayashi, J. Hetzel, Nik Hirani, L. Homik, Benjamin Hope-Gill, David Hotchkin, Kazuya Ichikado, M. M. Ilkovich, Yoshikazu Inoue, Shinyu Izumi, Ewa Jassem, Leonie Jones, S. Jouneau, Robert J. Kaner, Jian Kang, Tsuyoshi Kawamura, Romain Kessler, Y. Kim, Kazuma Kishi, Hideya Kitamura, Martin Kolb, Yasuhiro Kondoh, Chiyoko Kono, Dirk Koschel, Michael Kreuter, Tejaswini Kulkarni, Jan Kuś, F. Lebargy, Antonio León Jiménez, Qun Luo, Yolanda Mageto, Toby M. Maher, Shigeki Makino, S. Marchand‐Adam, Charles‐Hugo Marquette, Raquel Martínez, Martin Ulises Gutierrez Martinez and 68 more - The Lancet Respiratory Medicine 2020 cited by 559

  4. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , René‐Marc Flipo, Hilario Nunès, Dominique Valeyre, Nathalie Saidenberg-Kermanac’h, Marie‐Christophe Boissier, S. Marchand‐Adam, Aline Frazier, Pascal Richette, Yannick Allanore, Jean Sibilia, Claire Dromer, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Nadia Nathan, Serge Amselem, Martin Soubrier, Vincent Cottin, Annick Clément, Kevin D. Deane, Avram Walts, Tasha E. Fingerlin, Aryeh Fischer, Jay H. Ryu, Eric L. Matteson, Timothy B. Niewold, Deborah Assayag, Andrew Gross, Paul J. Wolters, Marvin I. Schwarz, Michael Holers, Joshua J. Solomon, Tracy J. Doyle, Iván O. Rosas, Cornelis Blauwendraat, Mike A. Nalls, Marie‐Pierre Debray, Cathérine Boileau, Bruno Crestani, David A. Schwartz, Philippe Dieudé - New England Journal of Medicine 2018 cited by 502

  5. Methotrexate and rheumatoid arthritis associated interstitial lung disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie‐Christophe Boissier, Lidwine Wémeau-Stervinou, René‐Marc Flipo, S. Marchand‐Adam, Pascal Richette, Yannick Allanore, Claire Dromer, Marie‐Elise Truchetet, Christophe Richez, Thierry Schaeverbeke, H. Lioté, Gabriel Thabut, Kevin D. Deane, Joshua J. Solomon, Tracy J. Doyle, Jay H. Ryu, Iván O. Rosas, V. Michael Holers, Cathérine Boileau, Marie‐Pierre Debray, Raphaël Porcher, David A. Schwartz, Robert Vassallo, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2020 cited by 236

  6. A Risk Score to Detect Subclinical Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2022 cited by 112

  7. Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Théodora Bejan‐Angoulvant, Vincent Cottin, S. Marchand‐Adam - European Respiratory Journal 2023 cited by 121

  8. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2016 cited by 1,197

  9. Neutrophil hyperactivation correlates with Alzheimer's disease progression

    Authors: , , , , , , , , , , , , - Annals of Neurology 2018 cited by 184

  10. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2020 cited by 253

  11. Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON

    Authors: , , , , , , , , , , - The Lancet Respiratory Medicine 2018 cited by 239

  12. Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis

    Authors: , , - European Respiratory Review 2023 cited by 74

  13. Physiology of the lung in idiopathic pulmonary fibrosis

    Authors: , , , , , - European Respiratory Review 2018 cited by 255

  14. Human inherited CCR2 deficiency underlies progressive polycystic lung disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jean‐François Emile, Pierre Le Guen, Guido Tavazzi, Costanza Natalia Julia Colombo, Federico Capra Marzani, Micol Angelini, Francesca Trespidi, Stefano Ghirardello, Nasrin Alipour, Anne Molitor, Raphaël Carapito, Mohsen Mazloomrezaei, Hassan Rokni‐Zadeh, Majid Changi‐Ashtiani, Chantal Brouzes, Pablo Vargas, A. Borghesi, Nico Lachmann, Seiamak Bahram, Bruno Crestani, Michaël Fayon, François Galodé, Susanta Pahari, Larry S. Schlesinger, Nico Marr, Dusan Bogunovic, Stéphanie Boisson‐Dupuis, Vivien Béziat, Laurent Abel, Raphaël Borie, Lisa R. Young, Robin R. Deterding, Mohammad Shahrooei, Nima Rezaei, Nima Parvaneh, Daniel Craven, Philippe Gros, Danielle Malo, Fernando E. Sepulveda, Lawrence M. Nogee, Nathalie Aladjidi, Bruce C. Trapnell, Jean‐Laurent Casanova, Jacinta Bustamante - Cell 2023 cited by 53

  15. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2020 cited by 96

  16. European Respiratory Society statement on familial pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , - European Respiratory Journal 2022 cited by 113

  17. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGF 1-induced fibroblast differentiation into myofibroblasts

    Authors: , , , , , - Thorax 2010 cited by 335

  18. Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesco Puppo, Sara Tomassetti, Valentina Luzzi, Nurdan Köktürk, Nesrin Moğulkoç, Christine Fiddler, Nikhil Hirani, Gísli Jenkins, Toby M. Maher, Philip L. Molyneaux, Helen Parfrey, Rebecca Braybrooke, Timothy S. Blackwell, Peter Jackson, Steven D. Nathan, Mary K. Porteous, Kevin K. Brown, Jason D. Christie, Harold R. Collard, Oliver Eickelberg, Elena Foster, Kevin F. Gibson, Marilyn K. Glassberg, Daniel J. Kass, Jonathan A. Kropski, David J. Lederer, A. Linderholm, Jim Loyd, Susan Mathai, Sydney B. Montesi, Imre Noth, Justin M. Oldham, Amy Palmisciano, Cristina Reichner, Mauricio Rojas, Jesse Roman, Neil W. Schluger, Barry S. Shea, Jeffrey J. Swigris, Paul J. Wolters, Yingze Zhang, Cecilia M. Prêle, Juan Ignacio Enghelmayer, María Otaola, Christopher J. Ryerson, Mauricio Salinas, Martina Šterclová, Tewodros Haile Gebremariam, Marjukka Myllärniemi, Roberto G. Carbone, Haruhiko Furusawa, Masaki Hirose, Yoshikazu Inoue, Yasunari Miyazaki, Ken Ohta, Shin Ohta, Tsukasa Okamoto, Dong Soon Kim, Annie Pardo, Moisés Selman, Alvaro U. Aranda, Moo Suk Park, Jong Sun Park, Jin Woo Song, María Molina‐Molina, Lurdes Planas‐Cerezales, Gunilla Westergren‐Thorsson, Albert V. Smith, Ani Manichaikul, John S. Kim and 15 more - American Journal of Respiratory and Critical Care Medicine 2023 cited by 80

  19. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Vincent Cottin, Marie‐Christophe Boissier, B. Wallaert, Thierry Schaeverbeke, F. Moal, Aline Frazier, Christelle Ménard, Martin Soubrier, Nathalie Saidenberg-Kermanac’h, Dominique Valeyre, Serge Amselem, Cathérine Boileau, Bruno Crestani, Philippe Dieudé - European Respiratory Journal 2017 cited by 233

  20. Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials

    Authors: , , , , , , , , - BMJ Open Respiratory Research 2019 cited by 207

  21. Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Thorax 2017 cited by 201

  22. European Respiratory Society statement on long COVID follow-up

    Authors: , , , , , , , , , , , , - European Respiratory Journal 2022 cited by 157

  23. Graph Technology in Reverse Engineering: The TGraph Approach

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marie-Pierre Debray, Alexandra Rousseau, Mallorie Kerjouan, Olivia Freynet, Marie-Christine Dombret, Anne-Sophie Gamez, Ana Nieves, Guillaume Beltramo, Jean Pastré, Aurélie Le Borgne-Krams, Tristan Dégot, Claire Launois, Laurent Plantier, Lidwine Wémeau-Stervinou, Jacques Cadranel, Cécile Chenivesse, Dominique Valeyre, Bruno Crestani, Vincent Cottin, Tabassome Simon, Hilario Nunes - The Lancet Respiratory Medicine 2008 cited by 119

  24. Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom van der Poll, Harm Jan Bogaard, Robert F. J. Kullberg, Shiqi Zhang, Esther J. Nossent, Leo M. A. Heunks, Pieter Roel Tuinman, Peter I. Bonta, Laurent Abel, Saleh Al-Muhsen, Andrés A. Arias, Dusan Bogunovic, Alexandre Bolze, Ahmed A. Bousfiha, Davood Mansouri, Isabelle Meyts, Rebeca Perez de Diego, Vanessa Sancho-Shimizu, András N. Spaan, Stuart G. Tangye, Shen-Ying Zhang, Helen C. Su, Julien Mayaux, Qian Zhang, Emmanuelle Jouanguy, Raphael Borie, Bruno Crestani, Charles Edouard Luyt, Homa Adle-Biassette, Damien Sene, Bruno Megarbane, Aurélie Cobat, Paul Bastard, Lieuwe D. J. Bos, Jean-Laurent Casanova, Anne Puel - Journal of Clinical Immunology 2023 cited by 33